Case series:Dapagliflozin

3 trials

Sponsors

Qingdao Central Hospital, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Department of Hypertension and Vascular Disease, the First Affiliated Hospital of Sun Yat-Sen University

Conditions

DiabetesDiabetes mellitusType 2 diabetes

Phase 4

Construction of efficacy prediction model for dapagliflozin with genetic variation combined with serum metabolites

Active, not recruitingChiCTR1900028227

Shanghai Jiao Tong University Affiliated Sixth People's HospitalType 2 diabetes

Start: 2020-01-01Updated: 2019-12-16

Dapagliflozin rescues vasculogenic capacity of endothelial progenitor cells in diabetes

Active, not recruitingChiCTR2100047733

Department of Hypertension and Vascular Disease, the First Affiliated Hospital of Sun Yat-Sen UniversityDiabetes mellitus

Start: 2020-02-01Updated: 2022-02-28

Unknown Phase

Effects of Dapagliflozin on blood glucose and metabolic parameters in patients with type 2 diabetes mellitus

Active, not recruitingChiCTR1800019332

Qingdao Central HospitalDiabetes

Start: 2018-11-20Updated: 2018-11-19